期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
ApoE和SLCO1B1基因指导瑞舒伐他汀调脂的临床研究
1
作者 赵国敏 赵磊 +2 位作者 张辉 叶朴聪 陈炜 《中国临床药理学杂志》 CAS CSCD 北大核心 2024年第22期3219-3223,共5页
目的 研究载脂蛋白E(ApoE)基因、溶质载体有机阴离子转运蛋白家族1B1(SLCO1B1)基因指导瑞舒伐他汀调脂的有效性及安全性。方法 将血脂异常患者根据ApoE基因型分为E2组(ε2/ε2、ε2/ε3)、E3组(ε3/ε3、ε2/ε4)、E4组(ε3/ε4、ε4/ε... 目的 研究载脂蛋白E(ApoE)基因、溶质载体有机阴离子转运蛋白家族1B1(SLCO1B1)基因指导瑞舒伐他汀调脂的有效性及安全性。方法 将血脂异常患者根据ApoE基因型分为E2组(ε2/ε2、ε2/ε3)、E3组(ε3/ε3、ε2/ε4)、E4组(ε3/ε4、ε4/ε4);根据SLCO1B1基因型分为TT组(*1a/*1a、*la/*1b、*lb/*lb)、TC组(*la/*5、*1a/*15、*lb/*15)、CC组(*15/*15)。所有患者均给予瑞舒伐他汀钙片,每次10 mg,每晚1次,口服,持续治疗6个月。比较3组ApoE基因型患者的三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)水平,比较3组SLCO1B1基因型患者谷丙转氨酶(GPT)、谷草转氨酶(GOT)、肌酸激酶(CK)、肌酸酐(Cr)、空腹血糖(FBG)和糖化血红蛋白(HbA1C)水平,观察研究期间患者肌痛的发生情况。结果 共纳入1 693例患者,其中,E2组204例、E3组1 226例、E4组263例;其中,TT组1 340例、TC组334例、CC组19例。经瑞舒伐他汀治疗后,E2组、E3组、E4组的TG水平分别为(1.34±1.17)、(1.20±0.43)和(1.34±0.55)mmol·L^(-1),LDL-C水平分别为(1.84±0.52)、(2.09±0.66)和(2.25±0.51)mmol·L^(-1),HDL-C水平分别为(1.20±0.26)、(1.13±0.27)和(1.01±0.21)mmol·L^(-1)。E2组的TG和LDL-C水平均较E3组和E4组显著下降,E2组和E3组的HDL-C水平均较E4组显著升高(均P<0.05)。经瑞舒伐他汀治疗后,CC组的CK水平均显著高于TT组和TC组(113 vs 96、94 U·L^(-1),均P<0.05)。TT组、TC组、CC组的肌痛发生率分别为3.13%、5.99%和10.53%,在统计学上差异均有统计学意义(均P<0.05)。结论 经瑞舒伐他汀治疗后,ε2等位基因与E2/E3基因型能够更有效地降低血脂异常患者的TG和LDL-C水平;SLCO1B1 521T>C:CC基因型患者更加容易出现肌痛现象,521T>C各基因型均未导致糖尿病出现。 展开更多
关键词 瑞舒伐他汀钙片 载脂蛋白E基因 溶质载体有机阴离子转运蛋白家族1B1 基因多态性 脂异常
原文传递
The Activity of Serum 8-Iso-Prostaglandin F2α as Oxidative Stress Marker in Patients with Diabetes Mellitus Type 2 and Associated Dyslipidemic Hyperglycemia
2
作者 Mohammed H. Mukhtar Hoda M. El-Emshaty +1 位作者 Hiba S. Alamodi Wesam A. Nasif 《Journal of Diabetes Mellitus》 2016年第4期318-332,共15页
Background: Oxidative stress has been closely linked to the incidence of diabetic complications. Therefore, the aim of this research article was to study hyperglycemia and abnormal lipid profile in diabetic patient ty... Background: Oxidative stress has been closely linked to the incidence of diabetic complications. Therefore, the aim of this research article was to study hyperglycemia and abnormal lipid profile in diabetic patient type 2 and its correlation with oxidative stress development as measured by 8-iso-PGF2α and 8-OHdG. Methods: Fifty (50) patients confirmed type 2 diabetes mellitus and eighty (80) non-diabetic control individuals were included in this study. All individuals were tested for blood glucose, lipid profile, 8-iso-PGF2α and 8-OHdG HdG. Results: The age of diabetic patients was observed to be ≥40 yrs in 96% and diabetes was frequently detected in female than in male patients (76% vs. 24%, p ere elevated in diabetic patients compared with control individuals (p < 0.0001) except in HDL-C, a significant decrease was recorded (p = 0.04). Serum 8-iso-PGF2α and 8-OHdG were elevated significantly in diabetic patients compared with non-diabetic control and a significant correlation was recorded between them (r = 0.6, p α was associated with Age (r = 0.394, p < 0.0001), FBG (0.553, p < 0.0001), LDL-C (r = 0.2, p = 0.023), TG (r = 0.176, p = 0.045) and TC (r = 0.2, p = 0.02). Also, 8-OHdG was associated with age (r = 0.558, p < 0.0001), FBG (r = 0.67, p < 0.0001), LDL-C (r = 0.28, p = 0.001), TG (r = 0.358, p < 0.0001) and TC (r = 0.33, p < 0.0001). Age, FBG, HbA1c, LDL-C, TG and TC showed a significant linear regression with 8-iso-PGF2α and 8-OHdG recording its role as significant predictors for the elevation of 8-iso-PGF2α and 8-OHdG. Therefore, hyperglycemia with oxidative stress development may play a role for dyslipidemia and diabetic complications. Conclusion: Diabetic patient’s type 2 has a higher rate of abnormal serum lipids and correlates significantly with lipid peroxidation and oxidized DNA bases as measured by 8-iso-PGF2α and 8-OHdG. Therefore, 8-iso-PGF2α and 8-OHdG could be used as oxidative biomarkers for evaluating diabetic patients with early prediction of its complications and cancer deve 展开更多
关键词 Diabetes Mellitus Type 2 8-ISO-PGF2Α 8-OHDG ELISA abnormal lipid profile
下载PDF
重庆市3717例人群糖尿病及相关疾病的调查 被引量:23
3
作者 任伟 张素华 +14 位作者 李革 李启富 倪银星 卢仙娥 马贵成 包柄楠 陈静 张政 汪志红 王继旺 吴静 杜娟 邓吉容 唐兰 黄维嘉 《重庆医学》 CAS CSCD 2005年第1期7-9,共3页
目的 了解重庆市糖尿病 (DM)、高血压 (HBP)、血脂紊乱及代谢综合征 (MS)等病的患病情况。方法 采用横断面调查方法对重庆市局部地区 3717例 2 0岁以上自然人群进行口服葡萄糖耐量试验 (OGTT)等调查。结果 DM、糖调节受损(IGR)、HBP... 目的 了解重庆市糖尿病 (DM)、高血压 (HBP)、血脂紊乱及代谢综合征 (MS)等病的患病情况。方法 采用横断面调查方法对重庆市局部地区 3717例 2 0岁以上自然人群进行口服葡萄糖耐量试验 (OGTT)等调查。结果 DM、糖调节受损(IGR)、HBP、血脂异常、超重 /肥胖、MS等病的患病率分别为 10 .38%、15 %、35 .4 3%、4 6 .95 %、30 .87% / 3.82 %、9.6 9%。各种疾病随年龄增加而增高 ,高甘油三酯血症、超重和肥胖的患病高峰年龄男性为 5 0岁 ,女性为 6 0岁。结论 重庆市糖尿病及相关疾病的患病率较高 ,应加强防治。 展开更多
关键词 葡萄糖 糖调节受损 高血压 血脂紊乱 代谢综合征 患病率
下载PDF
Prevalence of Dyslipidemia among Patients Received at the Biochemistry Unit of the Charles de Gaulle Pediatric University Hospital in Ouagadougou
4
作者 Fabienne Marie Soudre Arnaud Kouraogo +9 位作者 Alice Kiba Ollo Da Mahutin Benoîte Hounhoui Diema Nadia Karama Seraphine Mano Denis Claude Drabo Augustin Kyetega Raoul Karfo Elie Kabre Jean Sakande 《Advances in Biological Chemistry》 CAS 2024年第1期16-26,共11页
Introduction: Cardiovascular disease represents a major public health burden worldwide. Research and management of risk factors contribute to the prevention of these diseases. The aim of this study was to assess the p... Introduction: Cardiovascular disease represents a major public health burden worldwide. Research and management of risk factors contribute to the prevention of these diseases. The aim of this study was to assess the prevalence of dyslipidemia in the biochemistry unit of the Charles De Gaulle Pediatric University Hospital (CHUP-CDG) in Ouagadougou. Material and Methods: This was a descriptive and analytical cross-sectional study, with retrospective data collection from January 1, 2020 to December 31, 2022. Patients of all ages who performed a lipid panel in the CHUP-CDG biochemistry unit during the study period have been included. Results: A total of 2872 patients have been included. The mean age of the study population was 27.72 ± 19.51 years and the M/F sex ratio was 0.81. Among the patients, 22.84% had at least one dyslipidemia. The prevalences of hypercholesterolemia, hypo-HDL cholesterolemia and hyper-LDL cholesterolemia were 11.57%, 49.19% and 57.50% respectively. Hypertriglyceridemia and mixed hyperlipidemia were present in 9.04% and 2.08% of patients. Hypercholesterolemia was significantly more frequent in the female sex (p = 0.0077);hyper-LDL cholesterolemia (p = 0.0255) and mixed hyperlipidemia (p Conclusion: The relatively high prevalence of dyslipidemia in the study indicates a worrying situation. It would therefore appear essential to extend the search for risk factors nationwide, particularly those that can be modified, in order to reduce morbidity and mortality linked to cardiovascular disease. 展开更多
关键词 DYSlipidEMIA lipid profile lipid abnormalities PREVALENCE Burkina Faso
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部